Zometa® is effective and well tolerated in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy

✍ Scribed by R. Coleman; J. Apffelstaedt; D. Gordon; P. Major; J. Mackey; A. Howell; R. Theriault; Y. Yambros; B. Chen; D. Reitsma

• Book ID: 117658411
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 155 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81045-5